Acute coronary syndromes: a companion to Braunwald's heart disease
One of the leading experts in the field and a stellar cast of contributors provide all of the scientific and clinical information needed to facilitate rapid evaluation and immediate management of acute coronary syndromes using today's full range of strategies-from pharmaceutical approaches to revascularization. Readers will also find coverage of special considerations for specific populations and care settings, as well as the recent guidelines from the AHA/ACC and ESC Task Forces for the management of these challenging, life-threatening syndromes. Examines the molecular mechanisms of acute coronary syndromes, inflammation and immunity. Explains the function of the endothelium and its role in atherosclerosis. Explores all of the current methods of diagnosis and provides outcomes data for each modality, encompassing ECG, biochemical markers, angiography, nuclear cardiology, echocardiography, MRI, CT, and more. Covers today's full range of available management strategies, including antiplatelet therapy, gene therapy, and pharmaceutical approaches to inflammation, revascularization, and more. Discusses special considerations for the care of acute coronary syndromes in the ED and CCU. Offers guidance on the management of special populations and chronic patients. Includes guidelines for management of acute coronary syndromes from the AHA/ACC and ESC Task Forces, with commentary from Eugene Braunwald, MD and Michel Bertrand, MD.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Cardiovascular Regeneration and 649 SECTION
Eugene Braunwald SECTION 3
Clinical Practice 12 Acute Coronary Syndromes in
30 other sections not shown
abciximab activation acute coronary syndromes acute myocardial infarction angina pectoris angioplasty anticoagulant aspirin assessment associated atherosclerosis atherosclerotic plaques bivalirudin blood C-reactive protein cardiac events cardiac troponin cardiovascular cells chest pain cholesterol Circulation Clin clinical clopidogrel Coll Cardiol coro coronary angiography coronary artery disease death depression diabetes diagnosis dose early invasive echocardiography effects electrocardiogram endothelial Engl enoxaparin evaluation FRISC function gene glycoprotein heart disease heparin hypertension Ilb/IIIa imaging increased infection inflammation inflammatory inhibition inhibitor ischemic Lancet left ventricular lesions levels lipoprotein markers metabolic mortality myocardial ischemia myocardium nary nitrates non-ST-segment occlusion outcome oxidation patients with acute patients with unstable perfusion placebo plasma platelet predictive randomized receptor recurrent reduced reperfusion revascularization risk factors risk score risk stratification ST-segment elevation stenosis strategy stress symptoms therapy thrombin Thrombolysis thrombosis thrombus TIMI tion tirofiban tissue treatment trial troponin unfractionated heparin unstable angina unstable coronary vascular